Navigation Links
Medicinal products susceptible to 'dose dumping' should be fully tested
Date:9/23/2009

Controlled release pills and capsules that show a tendency in the standard laboratory test toward "dose dumping" releasing their medicine in a faster and potentially unsafe manner in patients who have consumed alcohol should be withheld from the market until proven safe with testing in people. That's the conclusion of a review of existing studies in the September-October issue of ACS' Molecular Pharmaceutics, a bi-monthly journal.

In the article, Hans Lennerns analyzed the gastrointestinal factors that may contribute to dose dumping when a vulnerable formulation interacts with alcohol present in the stomach. However, these factors are highly variable and depend on individual drinking behavior, whether food is present in the stomach, and other circumstances. That makes it "almost impossible" to predict whether a patient will experience an overdose as a result of dose dumping.

Lennerns thus concludes that when laboratory testing of a product indicates that the drug will be released more quickly than intended, the product also should be tested in humans, or it should be re-formulated. Indeed, Lennerns believes that lab testing over a two hour period in a range of alcohol strengths is an "absolute minimum standard" in screening for dose dumping because products with a problem in the lab may also be dangerous to patients. Lennerns cites as an example a formulation of the pain medication hydromorphone, which was removed from the U.S. market when testing revealed that alcohol intake caused the risk of overdose. He noted, however, that there is currently a generic oxycodone product on the market in the European Union which will "most likely" lead to dose dumping in patients.


'/>"/>

Contact: Michael Woods
m_woods@acs.org
202-872-6293
American Chemical Society
Source:Eurekalert  

Page: 1

Related medicine news :

1. Medithrive Announces the Grand Opening of Its San Francisco Medicinal Marijuana Dispensary
2. Pharoahs Wine Jar Yields Medicinal Secrets
3. BioRelix and Dalton Medicinal Chemistry Expand and Renew Research Agreement to Capitalize on Riboswitches
4. European Committee for Human Medicinal Products (CHMP) Issues Positive Opinion for Once-Daily PREZISTA(R) (Darunavir) as Part of Combination Therapy for Treatment-Naive Adults With HIV-1
5. Medicinal Marijuana Eases Neuropathic Pain in HIV
6. Dr. Richard M. Soll Joined WuXi PharmaTech (NYSE: WX) as VP of Medicinal Chemistry
7. MS drug development agreement based on WEHIs medicinal chemistry
8. An Alternative to Medicinal Marijuana
9. Oriental Medicinal Herb Garden Dedication
10. Indian medicinal plant Acanthus ilicifolius may combat liver cancer
11. ATIR Classified as "Cell Based" Medicinal Product by the EMEA
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Medicinal products susceptible to 'dose dumping' should be fully tested
(Date:5/31/2016)... , ... May 31, 2016 , ... ... 4, 2016 Cool Vendors in Security Infrastructure Protection report by Gartner1 Inc. , ... a series of research reports evaluating these innovative vendors and their products and ...
(Date:5/31/2016)... (PRWEB) , ... May 31, 2016 , ... ... multichannel marketing services firm and statement solutions provider, for the tenth consecutive ... the May 2016 issue of Advertising Age, and SourceLink ranked eighteenth in the ...
(Date:5/31/2016)... N.J. (PRWEB) , ... May 31, 2016 , ... ... and print media enterprise focused on patients with cancer, has added Cancer ... readers and website visitors with more timely content on continuing successful careers while ...
(Date:5/30/2016)... ... May 30, 2016 , ... As the CDC relaxes ... children and their efforts to keep their households lice free. , According to ... enacting new policies that keep kids in the classroom despite the fact that they ...
(Date:5/30/2016)... ... May 30, 2016 , ... Zane Benefits, ... publication of an original infographic, " Health Benefits Reimbursement Compliance Timeline ." ... Zane Benefits complies with various federal regulations and reforms. , Navigating the new ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... ALBANY, New York , May 26, 2016 ... Transparency Market Research "Medical Waste Management Market - U.S. Industry ... the medical waste management market in the U.S. was valued ... expand at a CAGR of 3.4% from 2015 to 2023 ... report provides exhaustive analysis of current and emerging needle free ...
(Date:5/26/2016)... May 26, 2016   Change Healthcare ... analytics, network solutions and technology-enabled services designed ... entered into a strategic channel partnership with ... software solutions and revenue cycle management services ... and rehabilitation clinics to optimize revenue, operational ...
(Date:5/25/2016)... -- According to a new market research ... by Therapeutic Area (Oncology, Cosmeceutical/Plastic Surgery), by Application (Drug ... Hospitals/ Clinics) - Forecast to 2021", published by MarketsandMarkets, ... the forecast period of 2016 to 2021. This market ... from USD 117.3 Million in 2016, at a CAGR ...
Breaking Medicine Technology: